291 related articles for article (PubMed ID: 17472676)
21. The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis.
Duerr HP; Dietz K; Schulz-Key H; Büttner DW; Eichner M
Int J Parasitol; 2004 Mar; 34(4):463-73. PubMed ID: 15013736
[TBL] [Abstract][Full Text] [Related]
22. [Ocular onchocerciasis in Israel].
Oshry T; Lifshitz T; Wender A; Yassur Y
Harefuah; 1995 Jan; 128(2):80-2, 128, 127. PubMed ID: 7721179
[TBL] [Abstract][Full Text] [Related]
23. Onchocerciasis-associated limb swelling in a traveler returning from Cameroon.
Ezzedine K; Malvy D; Dhaussy I; Steels E; Castelein C; De Dobbeler G; Heenen M
J Travel Med; 2006; 13(1):50-3. PubMed ID: 16412109
[TBL] [Abstract][Full Text] [Related]
24. Proteinuria and onchocerciasis in an endemic area in Cameroon under community-based treatment with ivermectin.
Ebong CE; Alemnji GA; ; Ashuntantang G; Asonganyi T
Trop Doct; 2007 Jul; 37(3):156-8. PubMed ID: 17716503
[TBL] [Abstract][Full Text] [Related]
25. The effect of drug treatment on the pattern of emergence of Onchocerca volvulus microfilariae from skin snips.
Kale OO
J Helminthol; 1981 Jun; 55(2):79-83. PubMed ID: 7264274
[TBL] [Abstract][Full Text] [Related]
26. [Onchodermatitis (sowda) in patients in Yémen. Clinical and histologic course after treatment with ivermectin].
al Qubati Y; Reynouard F; Kumar F; Gaxotte P; Richard-Lenoble D
Sante; 1997; 7(6):391-5. PubMed ID: 9503497
[TBL] [Abstract][Full Text] [Related]
27. Studies on nodules and adult Onchocerca volvulus during a nodulectomy trial in hyperendemic villages in Liberia and Upper Volta. I. Palpable and impalpable onchocercomata.
Albiez EJ
Tropenmed Parasitol; 1983 Mar; 34(1):54-60. PubMed ID: 6682581
[TBL] [Abstract][Full Text] [Related]
28. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis.
Ali MM; Mukhtar MM; Baraka OZ; Homeida MM; Kheir MM; Mackenzie CD
Acta Trop; 2002 Oct; 84(1):49-53. PubMed ID: 12387910
[TBL] [Abstract][Full Text] [Related]
29. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
30. Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis.
Whitworth JA; Maude GH; Downham MD
Trop Med Int Health; 1996 Dec; 1(6):786-93. PubMed ID: 8980590
[TBL] [Abstract][Full Text] [Related]
31. Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control.
Schulz-Key H; Karam M; Prost A
Trop Med Parasitol; 1985 Dec; 36(4):244-8. PubMed ID: 4089476
[TBL] [Abstract][Full Text] [Related]
32. Late-onset onchocercal skin disease among Ethiopian immigrants.
Baum S; Greenberger S; Pavlotsky F; Solomon M; Enk CD; Schwartz E; Barzilai A
Br J Dermatol; 2014 Nov; 171(5):1078-83. PubMed ID: 24673403
[TBL] [Abstract][Full Text] [Related]
33. Treatment of onchocerciasis with ivermectin (Province of Bururi, Burundi): parasitologic and clinical evaluation of different periodicities of treatment.
Vyungimana F; Newell E
Am J Trop Med Hyg; 1998 Nov; 59(5):828-31. PubMed ID: 9840606
[TBL] [Abstract][Full Text] [Related]
34. Effects of Ivermectin with and without doxycycline on clinical symptoms of onchocerciasis.
Masud H; Qureshi TQ; Dukley M
J Coll Physicians Surg Pak; 2009 Jan; 19(1):34-8. PubMed ID: 19149978
[TBL] [Abstract][Full Text] [Related]
35. Onchocerciasis in a teenager from Africa.
Leake JA; Pong AL; Scher CA; Newbury RO; Cunningham BB
Arch Dermatol; 2004 Sep; 140(9):1161-6. PubMed ID: 15381564
[No Abstract] [Full Text] [Related]
36. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Gardon-Wendel N; Duke BO; Prichard RK; Boussinesq M
Parasitology; 2006 Feb; 132(Pt 2):255-62. PubMed ID: 16197589
[TBL] [Abstract][Full Text] [Related]
37. Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control.
Haddad D; Cross C; Thylefors B; Richards FO; Bush S; Hopkins AD; Baker SK
Glob Public Health; 2008; 3(2):187-96. PubMed ID: 19288370
[TBL] [Abstract][Full Text] [Related]
38. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of human onchocerciasis with ivermectin].
Coulaud JP; Larivière M; Gervais MC; Gaxotte P; Aziz A; Deluol AM; Cenac J
Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):681-8. PubMed ID: 6689518
[TBL] [Abstract][Full Text] [Related]
40. Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.
Brattig NW
Acta Trop; 2009 Sep; 111(3):201-2. PubMed ID: 19619685
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
